Abstract Number: 225 • 2016 ACR/ARHP Annual Meeting
Patterns of Joint Involvement in Gout Flares
Background/Purpose: Gout flares are the most common manifestations of gout. Awareness of possible disease presentations beyond the traditionally recognized podagra is essential for accurate and…Abstract Number: 226 • 2016 ACR/ARHP Annual Meeting
Comparing the Burden of Illness of Patients with Tophaceous and Non-Tophaceous Gout in France, Germany, Italy, Spain, UK, and USA
Background/Purpose: Less than 30% of gout patients achieve treatment targets and patients with tophi are less likely to achieve these goals than patients without tophi.…Abstract Number: 227 • 2016 ACR/ARHP Annual Meeting
Inadequately Treated Chronic Gout As the Main Reason for Primary Gout Admission in an Urban Adult Population: Results of a Retrospective Cohort Study
Background/Purpose: Inadequately treated patients with chronic gout are at risk for an acute attack and many often require hospitalization. An acute attack of gout increases…Abstract Number: 228 • 2016 ACR/ARHP Annual Meeting
Sick Leave and Disability Pension in Working-Age Gout Patients before and after Diagnosis – a Population Based Case-Control Study
Background/Purpose: Gout is the most common form of inflammatory arthritis with a prevalence of 1.5% in our area in the age group 50-59 years. Gout…Abstract Number: 229 • 2016 ACR/ARHP Annual Meeting
Relationship Between Patient and Disease Factors and Severity of Gout in a Real-World Population
Background/Purpose : Gout is the most prominent clinical manifestation of hyperuricemia, and is the most common cause of inflammatory arthritis. The symptoms of gout (eg,…Abstract Number: 230 • 2016 ACR/ARHP Annual Meeting
A Survey of Knowledge of Optimal Gout Management in an Academic Primary Care Setting
Background/Purpose: We reviewed previous treatment approaches for gout in patients referred to a university rheumatology practice for gout management. All patients met the 2015 American…Abstract Number: 231 • 2016 ACR/ARHP Annual Meeting
Impact of an Educational Program for the Management of Gout Directed to Primary Care Physicians
Background/Purpose: Gout is the most frequent inflammatory arthritis in males, and therefore a common cause for consultation in both primary care and specialist settings. Despite…Abstract Number: 232 • 2016 ACR/ARHP Annual Meeting
Impact of Gout Flare Prophylaxis and Urate-Lowering Therapy on Endothelial Function, Smooth Muscle Responsiveness and Markers of Inflammation: Results of a Prospective Observational Pilot Study
Background/Purpose: To date, most studies of gout and cardiovascular disease have been cross-sectional or retrospective, and have addressed the outcome of acute coronary syndromes. Less…Abstract Number: 233 • 2016 ACR/ARHP Annual Meeting
New Cardiovascular Risk Factors Screening in Patients with Gout
Background/Purpose: Gout is a disease triggered by the crystallization of uric acid in the joints secondary to persistent hyperuricemia, that leads to chronic inflammation. Patients…Abstract Number: 234 • 2016 ACR/ARHP Annual Meeting
Coexistent Gout and Rheumatoid Arthritis: Comparison of Comorbidity, Autoantibodies, Disease Measures, and All-Cause Mortality
Background/Purpose: Coexistent RA and gout were previously believed to be exceedingly rare due to several hypothesized mechanisms encompassing inhibition of crystal formation, deposition, and activation.…Abstract Number: 294 • 2016 ACR/ARHP Annual Meeting
Serum Urate Levels Predict Joint Space Narrowing in Non-Gout Patients with Medial Knee Osteoarthritis
Background/Purpose: Osteoarthritis (OA) etiopathogenesis includes an inflammatory component. Published reports indicate that synovial fluid urate levels, even in patients without gout, associate with OA prevalence/severity.…Abstract Number: 1013 • 2016 ACR/ARHP Annual Meeting
The Risk of Colchicine Associated Myopathy in Gout: Influence of Concomitant Use of Statin
Background/Purpose: To investigate the risk of concomitant use of statin on the development of myopathy in gout patients who received colchicine. Methods: We included patients…Abstract Number: 1148 • 2016 ACR/ARHP Annual Meeting
Implementation of a Gout Knowledge Based Assessment Tool in an Inter-Professional, Multi-Disciplinary Musculoskeletal Training Program
Background/Purpose: The Musculoskeletal (MSK) Education Week is an interprofessional, multidisciplinary, multilevel training initiative launched in 2012. In 2015, this program was expanded to include a…Abstract Number: 1157 • 2016 ACR/ARHP Annual Meeting
Using Goutpro to Make Medical Trainees Gout Pros
Background/Purpose: Gout is the most common type of inflammatory arthritis in the U.S., affecting 4% of the population. Gout also has a large impact on…Abstract Number: 1218 • 2016 ACR/ARHP Annual Meeting
Extensive Genetic Overlap of Traits Related to Gout, Hyperuricemia and Its Comorbidities
Background/Purpose: Gout and hyperuricemia (serum urate > 7 mg/dL) typically present in the context of one or more comorbidities including type-2 diabetes, chronic renal disease,…
Simple Search Results
Didn't find what you were looking for? Try the Advanced Search »
Didn't find what you were looking for? Try the Advanced Search »